Department of Bone Tumor, Tianjin Hospital, Tianjin, China.
Graduate School, Tianjin Medical University, Tianjin, China.
Orthop Surg. 2019 Oct;11(5):725-737. doi: 10.1111/os.12509. Epub 2019 Sep 8.
Reconstruction of massive bone defects is challenging for orthopaedic clinicians, especially in cases of severe trauma and resection of tumors in various locales. Autologous iliac crest bone graft (ICBG) is the "gold standard" for bone grafting. However, the limited availability and complications at donor sites resulted in seeking other options like allografts and bone graft substitutes. Demineralized bone matrix (DBM) is a form of allograft using acidic solution to remove mineral components, while leaving much of the proteinaceous components native to bone, with small amounts of calcium-based solids, inorganic phosphates, and some trace cell debris. It is an osteoconductive and osteoinductive biomaterial and is approved as a medical device for use in bone defects and spinal fusion. To pack consistently into the defect sites and stay firmly in the filling parts, DBM products have various forms combined with biocompatible viscous carriers, including sponges, strips, injectable putty, paste, and paste infused with chips. The present review aims to summarize the properties of various kind of viscous carriers and their clinical use combined with DBM in commercially available products. Given DBM'mercially available products. Given DBM;s long clinical track record and commercial accessibility in standard forms, opportunities to further develop and validate DBM as a versatile bone biomaterial in orthopaedic repair and regenerative medicine contexts are attractive.
重建大段骨缺损对矫形临床医生来说是一项挑战,尤其是在严重创伤和各部位肿瘤切除的情况下。自体髂嵴骨移植物(ICBG)是骨移植的“金标准”。然而,供体部位的可用性有限和并发症导致人们寻求其他选择,如同种异体移植物和骨移植替代物。脱矿骨基质(DBM)是使用酸性溶液去除矿物质成分的同种异体移植物形式,而保留了骨中许多天然的蛋白质成分,少量基于钙的固体、无机磷酸盐和一些微量细胞碎片。它是一种具有骨传导性和骨诱导性的生物材料,已被批准为医疗器械,可用于骨缺损和脊柱融合。为了将 DBM 产品一致地填充到缺损部位并牢固地固定在填充部位,其具有各种形式,与生物相容性粘性载体结合使用,包括海绵、条带、可注射腻子、糊剂和与芯片混合的糊剂。本综述旨在总结各种粘性载体的特性及其与市售 DBM 产品联合使用的临床应用。鉴于 DBM 在标准形式下具有长期的临床记录和商业可及性,进一步开发和验证 DBM 作为一种在矫形修复和再生医学背景下具有多功能的骨生物材料的机会具有吸引力。